Literature DB >> 29865999

Theranostics of Gold Nanoparticles with an Emphasis on Photoacoustic Imaging and Photothermal Therapy.

Yi Liu1, Wenhui Ma1, Jing Wang1.   

Abstract

Gold nanoparticles (AuNPs) are promising biomedical agents in terms of both imaging and therapy, exhibiting excellent physical and chemical characteristics. The actions of AuNPs can be remotely controlled using strong near-infrared (NIR) light, associated with minimal lateral invasion. Employing the photoacoustic (PA) principle, AuNPs integrate imaging and temperature control, affording both diagnosis and treatment mediated by NIR light. We here review recent progress in the theranostic field employing AuNPs to both PA and photothermal ends. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Gold nanoparticles; minimal lateralzzm321990invasion; photoacoustic (PA) principle; photoacoustic imaging; photothermal therapy; theranostics.

Mesh:

Substances:

Year:  2018        PMID: 29865999     DOI: 10.2174/1381612824666180604112201

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Antitumor effects of targeted killing of tumor-associated macrophages under photothermal conditions.

Authors:  Bo Wang; Ying Huang
Journal:  Lasers Med Sci       Date:  2021-01-13       Impact factor: 3.161

2.  Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells.

Authors:  Channay Naidoo; Cherie Ann Kruger; Heidi Abrahamse
Journal:  Oncotarget       Date:  2019-10-22

3.  A colorful approach towards developing new nano-based imaging contrast agents for improved cancer detection.

Authors:  Helen R Salinas; Dominie L Miyasato; Olga E Eremina; Rodolfo Perez; Karen L Gonzalez; Alexander T Czaja; Sean Burkitt; Arjun Aron; Augusta Fernando; Lauro S Ojeda; Kimberly N Larson; Ahmed W Mohamed; Jos L Campbell; Beth A Goins; Cristina Zavaleta
Journal:  Biomater Sci       Date:  2020-08-19       Impact factor: 6.843

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.